Dr. Subhankar Chakraborty , M.B.B.S., Ph.D, M.D.
Internal Medicine Specialist

Omaha, Nebraska, USA

2004 

M.B.B.S. 

Andhra Medical College 

 

2011

Ph.D

University of Nebraska Medical Center 

 

2014

M.D.

University of Nebraska Medical Center 

Finalist for the “Non-resident Indian of the year 2013” award by ICICI Bank
Honorable Mention for poster “Multiple Myeloma patients are at an increased risk for a Second Lymphohematopoietic Malignancy- a SEER database based study” American College of Physicians, Nebraska chapter meeting on October 4, 2012
Member of winning team of “Doctor’s dilemma” at the American College of Physicians, Nebraska chapter meeting on October 4, 2012
Norman and Beatrice Harris Graduate Students in Cancer Research Award by the Harris Foundation (2011)
Norman and Beatrice Harris Graduate Students in Cancer Research Award by the Harris Foundation (2010)
Norman and Beatrice Harris Graduate Students in Cancer Research Award by the Harris Foundation (2009)
Research Innovation Award for new invention notification (2009) from University of Nebraska Medical Center, NE
Breast Cancer Research Program Predoctoral Award Department of Defense (2008-2011) from United States Department of Defense
University of Nebraska Medical Center Graduate Fellowship (2008-2011)
Rao Bahadur Dr. V.K. Narayana Menon Medal in Biochemistry (2000)
Biochemistry Prize for securing the highest marks in Biochemistry in the University examinations in M.B.B.S. (2000)
Drs C. Sita Devi and C.R.R.M. Reddy Endowment Award in Biochemistry in M.B.B.S. (2000)
 

American Medical Association (2011- present)
American College of Physicians (2011- present)
Nebraska Medical Association (2011- present)
American Pancreatic Association (2011- present)
International Liver Transplantation Society (2014 onwards)
British Science Society (2014 onwards)
Editor-in-chief, Free Radicals and Antioxidants (2010- present)
Editor-in-chief, Oncology, Gastroenterology and Hepatology Reports (2012-present)
Co-Editor, International Journal of Medicine and Public Health (2010- December 2012)
Editor-in-Chief, International Journal of Medicine and Public Health (January 2013 onwards)
Member of the International Editorial Board, Journal of Clinical Pathology (2011- present)
Member of Editorial Board, Journal of Pharmaceutical Technology and Drug Research (2011- present)
Member of the Editorial Board, Journal of Scientific Abstracts (2011- present)
Section Editor, Pancreatic diseases, Gastroenterology and Hepatology from Bed to Bench (2011- present)
Member of Editorial Board, Gastroenterology and Hepatology from Bed to Bench (2011- present)
Member of Editorial Board, World Journal of Gastrointestinal Pathophysiology (2011- present)
Member of the Resident Council, University of Nebraska Medical Center Veteran affairs Resident Clinic (2011- present)
Member of the Nebraska Oncologic Society (2011- present)
Member of the American Association for Cancer Research (2009-2011)
Student Representative, Dept. of Biochemistry and Molecular Biology (2008-2009)
International Advisory Board Member, Medica Innovatica (2012-present)
Member of Advisory Committee- International Conference of Herbal and Traditional Medicine, October 26-28 2012
(New Delhi, India)
Member of the Internal Medicine Research Council, University of Nebraska Medical Center (2013-2014)
 

Peer-reviewed publications
1     Chakraborty.S. , Kaur,S., Muddana,V., Sharma,N., Wittel,U.A., Papachristou,G.I., Whitcomb,D., Brand,R.E., Batra,S.K.. Elevated Serum Neutrophil Gelatinase-Associated Lipocalin Is an Early Predictor of Severity and Outcome in Acute Pancreatitis. Am J Gastroenterol. 2010 Sep;105(9):2050-9. Epub 2010 Feb 23.
2     Chakraborty S., Moniaux N.,Yalniz M,Gonzalez J,Shostrom VK, Standop J,Lele SM,Ouellette M,Pour PM,asson AR,Brand RE,Hollingsworth MA,Jain M,and Batra SK. Early Diagnosis of Pancreatic Cancer-Neutrophil gelatinase associated lipocalin (NGAL) as a Marker of Pancreatic Intraepithelial Neoplasia. British Journal of Cancer. 2008; 98(9): 1540-1547.
3     Chakraborty S., Jain M, Sasson A. and Batra SK. MUC4 as a Diagnostic Marker in Cancer. Expert Opinion in Medical Diagnostics. 2008; 2(8): 891-910.
4     Chakraborty S., Bonthu N., Swanson BJ and Batra SK. Current Status of Mucins in the Skin: Physiological and Pathobiologic Implications. Cancer Letters. 2010 [Epub ahead of print]
5     Chakraborty S, Swanson BJ, Bonthu N, Batra SK.. Aberrant upregulation of MUC4 mucin expression in cutaneous condyloma acuminatum and squamous cell carcinoma suggests a potential role in the diagnosis and therapy of skin diseases. Journal of Clinical Pathology. 2010; 63(7): 579-584.
6     Chakraborty S, Ganti AK, Marr A, Batra SK. Lung cancer in women: role of estrogens. Expert Reviews in Respiratory Medicine. 2010; 4(4): 509-518.
7     Chakraborty S, Tarantolo SR, Treves J, Sambol D, Hauke RJ, Batra SK. Progressive Multifocal Leukoencephalopathy in an HIV-Negative Patient with Small Lymphocytic Leukemia following treatment with Rituximab. Case Rep Oncol 2011;4:136-142
8     Chakraborty S, Tarantolo SR, Batra SK, Hauke RJ. Incidence and Prognostic Significance of Second Primary Cancers in Renal Cell Carcinoma. Am J Clin Oncol. 2013 Apr;36(2):132-42
9     Chakraborty S, Kaur S, Guha S and Batra SK. Multifaceted role of Neutrophil Gelatinase Associated Lipocalin (NGAL) in Inflammation and Cancer. Biochim. Biophys. Acta 1826 (2012) 129-169.
10     Chakraborty S., Sharma P., Roman J. and Richards S. Where suspicion bore fruit- An unusual cause of abdominal pain in a 46 year old man. Internet Journal of Surgery. 2012 Volume 28 Number 5. DOI: 10.5580/2c9c
11     Chakraborty S., Hauke R.J., Bonthu N. and Tarantolo S.R.Increased Incidence of a Second Lymphoproliferative Malignancy in patients with Multiple Myeloma- A SEER based study. Anticancer Research 32 (10) 4507-4515
12     Chakraborty S., Gums J.J., Toole A and Fedderson J. Amiodarone Induced Myxedema Coma- A Case and Review of Literature. Archives of Medical Science DOI (digital object identifier): 10.5114/aoms.2013.35026
13     Chakraborty S., Smith L., Ganti A., Bonthu N and Batra S.K. Breast cancer survival of Hispanic women in the USA is influenced by country of origin. Asia Pacific Journal of Clinical Oncology 2013 Apr 1. doi: 10.1111/ajco.12063. [Epub ahead of print]
14     Chakraborty S , Shimizu T, Torres MP, Souchek JJ, Rachagani S, Kaur S, Macha M, Ganti AK, Hauke RJ, Batra SK. Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: Potential role in therapy. Cancer Lett. 2013 Aug 19;336(2):270-80.
15     Chakraborty S., DiMaio D. and Vanschooneveld T. Palpable maculopapular rash with elevated ESR: What is your diagnosis? Ups J Med Sci. 2013 Nov;118(4):285-6
16     Chakraborty S. and Singh S., Surgical resection improves survival in pancreatic cancer patients without vascular invasion- A population based study. Ann. Gastroenterol 2013; 26 (4): 346-352 Chakraborty S. In Silico Analysis Identifies Genes Common between Five Primary Gastrointestinal Cancer Sites with Potential Clinical Applications. Ann. of Gastroenterology (2014) 27, 1-14
17     Chakraborty S. Analysis of NHANES 1999-2002 Data Reveals Noteworthy Association of Alcohol Consumption with Obesity. Ann of Gastroenterology (2014) 27, 1-9
18     Chakraborty S. Multiple ring enhancing lesions in a patient with unilateral limb jerking. Revision submitted to the Central European Journal of Medicine.
19     Chakraborty S, Keenportz B, Woodward S, Anderson J, Colan D.Paraneoplastic Leukemoid Reaction in Solid Tumors. Am J Clin Oncol. 2013 Oct 18. [Epub ahead of print]
20     Chakraborty S, Donner M, Colan D.Fatal herpes encephalitis in a patient with small cell lung cancer following prophylactic cranial radiation--a case report with review of literature. Anticancer Res. 2013 Aug;33(8):3263-8
21     Tong Z.,Chakraborty S.,Sung B, Koolwal P., Kaur S., Aggarwal B.B., Mani S.A.,Batra S.K., and Guha S.. Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells. Cancer 2010 [Epub ahead of print]
22     Chaturvedi P., Singh A.P., Chakraborty S., Chauhan SC, Bafna S,.Meza JL, Singh PK, Hollingsworth MA, Mehta PM and Batra.SK. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. Cancer Research. 2008; 68(7): 2065-2070.
23     Chaturvedi,P.,Singh,A.P.,Moniaux,N.,Senapati,S.,Chakraborty,S.,Meza,J.L.,Batra,S.K. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to. Molecular Cancer Research. 2007; 5(4): 309-320.
24     Mimeault M, Johansson SL, Senapati S, Momi N, Chakraborty S, Batra SK. MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies. Cancer Letter. 2010; 295(1): 69-84.
25     Mukhopadhyay P., Chakraborty S., Ponnusamy M.P., Lakshmanan I., Jain M., Batra S.K. Mucins in the Pathogenesis of Breast Cancer: Implications in Diagnosis, Prognosis and Therapy. Biochim Biophys Acta. Apr 2011; 1815(2): 224–24
26     Baine M.J., Chakraborty S., Smith L.M., Mallya K., Sasson A.R., Brand R.E. and Batra S.K. Transcriptional Profiling of Peripheral Blood Mononuclear Cells in Pancreatic Cancer Patients Identifies Novel Genes with Potential Diagnostic Implications. PLoS One 2011;6:e17014. Ponnusamy MP, Lakshmanan I, Jain M, Das S, Chakraborty S, Dey P, Batra SK. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells. Oncogene 29 (42): 5741-5754.
27     Ponnusamy MP, Singh AP, Jain M, Chakraborty S, Moniaux N, Batra SK.. MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells. British Journal of Cancer. 2008; 99(3): 520-526.
28     Ponnusamy,M.P.,Deb,S.,Dey,P., Chakraborty.S., Rachagani,S.,Senapati,S., Batra,S.K.. RNA polymerase II associated factor 1/PD2 maintains self-renewal by its interaction with Oct3/4 in mouse embryonic stem cells. Stem Cells. 2009; 27(12): 3001-3011.
29     Senapati S, Ho SB, Sharma P, Das S, Chakraborty S, Kaur S, Niehans G, Batra SK.. Expression of intestinal MUC17 membrane-bound mucin in inflammatory and neoplastic diseases of the colon. J Clin Pathol. 2010; 8(63): 702-707.
30     Torres,M.P., Ponnusamy,M.P., Chakraborty,S., Smith,L.M., Das,S., Arafat,H.A., Batra,S.K.. Effects of .thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies. Molecular Cancer Therapy. 2010; 9(5): 1419-1431.
31     Wittel,U.A.,Wiech,T.,Chakraborty.S.,Boss,B.,Lauch,R.,Batra,S.K.,Hopt,U.T. Taurocholate-induced pancreatitis: a model of severe necrotizing pancreatitis in mice. Pancreas. 2008; 36(2): e9-e21.
32     Senapati S., Chaturvedi P, Chaney W.G., Chakraborty S., Gnanapragassam V. Sasson A.R. and Batra S.K.. Novel interaction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer. Clin. Cancer Res 17 (2011) pp. 267-274.
33     Wang G., Lipert R.J., Jain M., Kaur S., Chakraborty S., Torres M.P., Batra S.K., Brand R.E., Porter M.D. Sensitive Detection of the Potential Cancer Marker MUC4 using Surface-Enhanced Raman Scattering. Anal. Chem. 83 (2011) pp. 2554-2561.
34     Graham RP, Dry S, Li X, Binder S, Bahrami A, Raimondi SC, Dogan A, Chakraborty S, Souchek JJ, Folpe AL. Ossifying fibromyxoid tumor of soft parts: a clinicopathologic, proteomic, and genomic study. Am J Surg Pathol. 2011;35(11):1615-25.
35     Torres MP, Chakraborty S, Souchek J and Batra SK. Mucin-based Targeted Pancreatic Cancer Therapy. Curr Pharm Des. 2012 [Epub ahead of print]
36     Baine M., Sahaq F., Lin C., Chakraborty S., Lyden E. and Batra S.K., Marital status and survival in pancreatic cancer patients: a SEER based analysis. PLoS ONE 2011;6(6):e21052. Epub 2011 Jun 15.
37     Lakshmanan I.,Ponnusamy M.P.,Das S.,Chakraborty S.,Haridas D., Mukhopadhyay P., and Batra S.K.MUC16 Induced Rapid G2/M Transition via Interactions with Jak2 for Increased Proliferation and Anti-Apoptosis in Breast Cancer Cells. Oncogene. 2012 Feb 16; 31(7):805-17.
38     Jain M., Venkatraman G., Moniaux N., Kaur S., Kumar S., Chakraborty S., Varshney G.C. and Batra S.K. Monoclonal Antibodies Recognizing the Non-tandem Repeat Regions of the Human Mucin MUC4 in Pancreatic Cancer. PLoS One 2011;6(8):e23344. Epub 2011.
39     Haridas D, Chakraborty S, Ponnusamy MP, Lakshmanan I, Rachagani S, Cruz E, Kumar S, Das S, Lele SM, Anderson JM, Wittel UA, Hollingsworth MA, Batra SK. Pathobiological Implications of MUC16 Expression in Pancreatic Cancer. PLoS One. 2011;6(10):e26839. Epub 2011.
40     Horn A, Chakraborty S., Dey P., Haridas D., Souchek J, Batra S.K. and Lele S. Immunocytochemistry for MUC4 and MUC16 is a Useful Adjunct in the Diagnosis of Pancreatic Adenocarcinoma on Fine Needle Aspiration Cytology. Arch Pathol Lab Med. 2013 Apr;137(4):546-51
41     Dey P., Rachagani S., Chakraborty S., Singh P.K., Zhao X., Gurumurthy C.B., Anderson J., Lele S., Hollingsworth M.A., Band V and Batra S.K. Overexpression of Ecdysoneless (Ecd) in Pancreatic Cancer and its Role in Oncogenesis by Regulating Glycolysis. Clinical Cancer Research 2012 Nov 15;18(22):6188-98.
42     Baine MJ, Menning M, Smith LM, Mallya K, Kaur S, Rachagani S, Chakraborty S, Sasson AR, Brand RE, Batra SK. Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer. Cancer Biomark. 2011-2012; 11(1):1-14.
45.     Singh S., Chakraborty S, Bonthu N., Radio S., Hussain S.M. and Sasson A. Combined Hepatocellular Cholangiocarcinoma- Epidemiology, Diagnosis And Therapy Of An Uncommon Malignancy. Digestive Disease and Sciences . DOI 10.1007/s10620-013-2585-1.
46.     Kaur S, Chakraborty S, Baine MJ, Mallya K, Smith LM, Sasson A, Brand R, Guha S, Jain M, Wittel U, Singh SK, Batra SK. Potentials of Plasma NGAL and MIC-1 as Biomarker(s) in the Diagnosis of Lethal Pancreatic Cancer. PLoS One. 2013;8(2):e55171. doi: 10.1371/journal.pone.0055171. Epub 2013 Feb 1.
47.     Kaur S, Baine MJ, Guha S, Ochi N, Chakraborty S, Mallya K, Thomas C, Crook J, Wallace MB, Woodward TA, Jain M, Singh S, Sasson AR, Skinner V, Raimondo M, Batra SK. Neutrophil Gelatinase-Associated Lipocalin, Macrophage Inhibitory Cytokine 1, and Carbohydrate Antigen 19-9 in Pancreatic Juice: Pathobiologic Implications in Diagnosing Benign and Malignant Disease of the Pancreas. Pancreas. 2013 Apr;42(3):494-501
48.     Mukhopadhyay P, Lakshmanan I, Ponnusamy MP, Chakraborty S, Jain M, Pai P, Smith LM, Lele SM, Batra SK. MUC4 Overexpression Augments Cell Migration and Metastasis through EGFR Family Proteins in Triple Negative Breast Cancer Cells PLoS One. 2013;8(2):e54455. doi: 10.1371/journal.pone.0054455. Epub 2013 Feb 11. PMID: 23408941

Manuscripts under review
1.     Kaur S, Momi N, Chakraborty S, Horn AJ, Lele SM, Theodorescu D, Frierson H and Batra SK. Altered expression of transmembrane MUC1 and MUC4 in urological cancers: Pathological implications in diagnosis

Book chapters

1     Subhankar Chakraborty, Sukhwinder Kaur, Zhimin Tong, Surinder K. Batra and Sushovan Guha (2011). Neutrophil Gelatinase Associated Lipocalin: Structure, Function and Role in Human Pathogenesis, Acute Phase Proteins - Regulation and Functions of Acute Phase Proteins, Francisco Veas (Ed.), ISBN: 978-953-307-252-4,InTech,Available from: http://www.intechopen.com/articles/show/title/neutrophil-gelatinase-associated-lipocalin-structure-function-and-role-in-human-pathogenesis

Books
1.     Chakraborty S., Beginners Guide to Research During Residency (ASIN: B00GSW6800).

Poster Presentation
1.     Chakraborty S., Shimizhu T., Gonzales M.T., Souchek J., Rachagani S., Macha M., Ganti A.K., Moore E.D. and Batra S.K.Downregulation of MUC4 by the extract and essential oil of Holy Basil leaves suggests a potential for Basil as a novel therapeutic adjuvant in pancreatic cancer. American Pancreatic Association meeting. November 2-5. 2011, Chicago.
2.     Chakraborty S, Moniaux N, Shostrom VK, Lele SM, Ouellette M, Sasson AR, Hollingsworth MA, and Batra.SK. (2008, September). NGAL/Lipocalin-2 is a marker of early dysplastic changes in the pancreas and a possible diagnostic marker in pancreatitis and/or pancreatic adenocarcinoma.. Poster presented at: Early Diagnostic Research Network; Seattle, WA.
3.     Chakraborty S, Nemos C, Jain M, Moore ED, Chaturvedi P, Moniaux N, Sasson A, Brand RE, Hauke RJ, Hollingsworth MA, Lele S, Sharma P and Batra.S.K.(2007, February). MUC4: a potential diagnostic and/or prognostic marker in pancreatic cancer.. Poster presented at: Midwest Student Biomedical Research Forum; Omaha, NE.Chakraborty S, Swanson BJ, Bonthu N, Batra SK. (2010, February). Expression of MUC4 mucin in cutaneous pathologies: Novel roles for diagnosis and therapy. Poster presented at: Midwest Student Biomedical Research Forum; Omaha, NE.
4.     Chakraborty S. , Muddana V, Papachristou G I, Kaur S, Sharma N, Whitcomb DC, Brand RE, Batra SK. (2009, May). Neutrophil associated gelatinase lipocalcin (NGAL) serum levels: Predicting severe acute pancreatitis as early as possible.. Poster presented at: Digestive Diseases Week; Chicago, IL.
5.     Chakraborty S., Kaur S, Moniaux N, Muddana V, Wittel UA, Mallya K, Papachristou GI, Whitcomb D, Sasson AR, Brand RE, Hollingsworth MA and Batra SK. (2009, November). NGAL from Pancreatitis to Pancreatic Cancer: Diagnostic and Prognostic Implications in Patients. Poster presented at: The 2009 National Cancer Institute Translational Science Meeting; Vienna, VA.
6.     Chakraborty S., Panapakkam Giridharan S.S., Mehta P., Batra S.K. (2009, April). 1,25-dihydroxy vitamin D3 represses MUC4 expression in pancreatic adenocarcinoma cells by recruitment of histone deacetylase complex. Poster presented at: American Association for Cancer Research; Denver, CO.
7.     Chakraborty S., Mukhopadhyay P., Jain M., Lakshmanan I., Ponnusamy M.P., Tomohiro S., Ganti A.K. and Batra S.K. Downregulation of MUC4 increases sensitivity of breast cancer cells to chemotherapy (August 2011) Poster presented at the Era of Hope Conference (US Department of Defense), Orlando, FL.
Mukhopadhyay P.,Ponnusamy M.P.
8.     Chakraborty S., Lakshmanan I., Subodh Lele,Jain M., and Batra S.K. Pathobiological implications of MUC4 mucin in basal/triple negative breast cancer cells (August 2011).Poster presented at the Era of Hope Conference (US Department of Defense), Orlando, FL.
9.     Deb S., Ponnusamy M.P., Dey P., Moniaux N., Nemos C., Chakraborty S., Lele S. and Batra S.K. A Novel Oncogene, PD2/HPAF1 in Breast Cancer. (August 2011) Poster presented at the Era of Hope Conference (US Department of Defense), Orlando, FL.
10.     Haridas D., Chakraborty S., Ponnusamy M.P., Lakshmanan I., Rachagani S., Lele S.M., Anderson J., Hollingsworth M.A., Batra S.K. (February 2011) Pathobiological implications of MUC16 in pancreatic cancer. Poster presented at: Midwest Student Biomedical Research Forum; Omaha, NE.
11.     Baine M, Chakraborty S., Smith L, Mallya K, Sasson AR, Batra SK. (2010, April). Transcriptional profiling in peripheral blood mononuclear cells of patients with pancreatic cancer identifies several genes with potential diagnostic and prognostic implications. Poster presented at: American Association for Cancer Research; Washington DC,DC.
12.     Baine M, Chakraborty S., Smith L, Mallya K, Sasson AR, Batra SK. (2010, February). Identification of differentially expressed transcripts in peripheral blood mononuclear cells of patients with pancreatic cancer yielding several genes with potential diagnostic and prognostic implications.. Poster presented at: Midwest Student Biomedical Research Forum; Omaha, NE.
13.     Deb S, Chakraborty S, Lele S,Chaudhary K, Sharma P and Batra SK. (2009, February). Expression of PD2/hPaf1 as a Potential Marker of Differentiation in Pancreatic Cancer.. Poster presented at: American Society for Clinical Pathology; Chicago, IL.
14.     Deb S, Chakraborty S, Lele S,Chaudhary K, Sharma P and Batra SK. (2008, April). Molecular studies on a novel and amplified gene, hPaf1, in pancreatic cancer. Poster presented at: American Association for Cancer Research; San Diego, CA.
15.     Dey P, Chakraborty S., Senapati S, Gurumurthy CB, Band V, Batra SK. (2010, April). Human Ecdysoneless Protein: A Novel Protein In Pancreatic Cancer Pathogenesis. Poster presented at: American Association for Cancer Research; Washington DC, DC.
16.     Dey P, Chakraborty S., Senapati S, Gurumurthy CB, Band V, Batra SK. (2010, February). Human Ecdysoneless protein: regulator of cholesterol homeostasis in pancreatic cancer. Poster presented at: Midwest Student Biomedical Research Forum; Omaha, NE.
17.     Horn A., Chakraborty S., Dey P., Haridas D., Gurumurthy C., Band V., Batra S.K. and Lele S.. (2011, February). Immunocytochemistry for MUC4, MUC16, NGAL and ECD as an adjunct in the diagnosis of fine needle aspiration cytology. Poster presented at: United States and Canadian Academy of Pathology; San Antonio, TX.
18.     Ponnusamy MP,Nelson R, Chakraborty S, Miller R, Lele SM and Batra SK. (2009, February). Expression of MUC4 and Palladin in ovarian cancer. Poster presented at: American Society for Clinical Pathology; Chicago, IL.
19.     Senapati S, Ho SB,Sharma P, Das S, Chakraborty S., Kaur S, Kandarian B, and Batra SK. (2010, May). Expression of intestinal MUC17 membrane-bound mucin in inflammatory and neoplastic diseases of the colon. Poster presented at: Digestive Diseases Week; Los Angeles, CA.
20.     Singh A.P., Chakraborty S., Singh S., Venkatraman G., Johansson S.L., Jain M., Bafna S., Batra S.K.. (2009, April). Expression of MUC4 is associated with the malignant phenotype of lung cancer cells. Poster presented at: American Association for Cancer Research; Denver, CO.
21.     Souchek J, Chakraborty S., Rachagani S, Hauke RJ and Batra SK. (2010, February). Reciprocal regulation of MUC4 and HER-2 by the anti-inflammatory corticosteroid Fluticasone propionate in pancreatic cancer cells-potential role in anti-cancer therapy. Poster presented at: Midwest Student Biomedical Research Forum; Omaha, NE.
22.     Souchek J, Chakraborty S., Rachagani S, Hauke RJ and Batra SK. (2010, April). Reciprocal regulation of MUC4 and HER-2 by the anti-inflammatory corticosteroid Fluticasone propionate in pancreatic cancer cells-potential role in anti-cancer therapy. Poster presented at: American Association for Cancer Research; Washington DC, DC.
23.     Macha, M.A., Rachagani, S, Chakraborty, S., Torres M.P., Ponnusamy, M.P. and Batra S.K (2011, November). The Novel Sterol Guggulsterone Modulates Novel microRNAs Targeting MUC4 Expression in Pancreatic Cancer Cells. Poster presented at: American Pancreatic Association Meeting, Chicago
24.     Kaur S., Chakraborty S., Lakshmanan I., Guha S., Batra S.K. (2011, November). Connecting the cords: Mucin MUC4 and Acute Phase Protein NGAL. Poster presented at: American Pancreatic Association Meeting, Chicago
25.     Haridas D., Chakraborty S., Ponnusamy M.P., Lakshmanan I., Rachagani S., Cruz E., Kumar S., Lele S., Anderson J.M., Wittel U.A., Hollingsworth M.A., and Batra S.K (2011, November). Pathobiological Roles of MUC16 (CA125) in Pancreatic Cancer. Poster presented at: American Pancreatic Association Meeting, Chicago
26.     Rachagani S., Macha M.A., Ponnusamy M.P., Chakraborty S., and Batra S.K (2011, November). MUC4 induces Epithelial Mesenchymal Transition through Ncadherin Upregulation in Pancreatic Cancer. Poster presented at: American Pancreatic Association Meeting, Chicago
27.     Chakraborty S., Shimizu T., Torres M.P., Souchek J., Rachagani S., Macha M., Ganti A.K., Moore E.D. and Batra S.K. Antiproliferative, Antiinvasive and Chemosensitizing Effects of Holy Basil leaf extracts in Human Pancreatic Cancer Cells Suggests its Potential Utility as a Source for Novel Anticancer Compounds. Abstract submitted to the American College of Physicians 2012 Meeting in April, 2012 (New Orleans)
28.     Chakraborty S., Sharma P., Roman J. and Richards S. Where suspicion bore fruit- An unusual cause of abdominal pain in a 46 year old man. Poster presented at: American College of Physicians Nebraska Chapter meeting October 4th 2012; Omaha. NE
29.     Chakraborty S. Multiple Myeloma patients are at an increased risk for a second lymphohematopoietic malignancy- a SEER database based study. Poster presented at: American College of Physicians Nebraska Chapter meeting October 4th 2012; Omaha. NE (Honorable Mention Award)
30.     Stone, J., Chakraborty S., Tape T and McComb R. An Unusual Cause of Foot Drop, GI bleed and Myocarditis in a 38 year old man. Poster presented at: American College of Physicians Nebraska Chapter meeting October 23, 2013; Omaha. NE
31.     Florescu D., Chakraborty S., Goodwin R., Kalil A and Mercer D. The Epidemiology of C. difficile Infections in Pediatric Small Bowel Transplantation; UNMC Experience. Submitted to the World Transplant Congress, 2014
32.     CMV sero-status, presence of jejunostomy and use of a proton pump inhibitor are associated with increased risk of C. difficile infection within the first year after pediatric small bowel transplantation. Chakraborty,S, Goodwin,R,Kalil, A,Mercer,D and Florescu,D. Abstract submitted to the 2014 Combined Annual Meeting of CSCTR and MWAFMR at Chicago (April 25-28)
33.     Liver function tests and occurrence of anemia, thrombocytopenia and leucopenia- retrospective cohort study in US adults. Chakraborty S., Bonthu N. and Singh S. Abstract submitted to the 2014 Combined Annual Meeting of CSCTR and MWAFMR at Chicago (April 25-28)


Oral presentations

1.     Chakraborty S., Gonzales M.T., Tomohiro S., Kaur S., Souchek J., Rachagani S., Lakshmanan I., Baine M.J., Ganti A.K., Hauke R.J., Moore E.D., Mukhopadhyay P., and Batra S.K.(February 2011). Potent anti-proliferative, anti-invasive and anti-migratory effects of Ocimum sanctum (holy basil) extract on pancreatic cancer cells. Oral presentation at: Midwest Student Biomedical Research Forum; Omaha, NE.
2.     Chakraborty S, Moniaux N, Shostrom VK, Lele SM, Ouellette M, Sasson AR, Hollingsworth MA, and Batra.SK. (2008, June). NGAL/Lipocalin-2 is a marker of early dysplastic changes in the pancreas and a possible diagnostic marker in pancreatitis and/or pancreatic adenocarcinoma.. Oral Presentation presented at: International Student Research Forum; Omaha, NE.
3.     Chakraborty S, Moniaux N, Shostrom VK, Lele SM, Ouellette M, Sasson AR, Hollingsworth MA, and Batra.SK. (2008, February). NGAL/Lipocalin-2 is a marker of early dysplastic changes in the pancreas and a possible diagnostic marker in pancreatitis and/or pancreatic adenocarcinoma.. Oral Presentation presented at: Midwest Student Biomedical Research Forum; Omaha, NE.
4.     Chakraborty S. , Muddana V, Papachristou G I, Kaur S, Sharma N, Whitcomb DC, Brand RE, Batra SK. (2009, February). Neutrophil associated gelatinase lipocalcin (NGAL) serum levels: Predicting severe acute pancreatitis as early as possible.. Oral Presentation presented at: Midwest Student Biomedical Research Forum; Omaha, NE.
5.     Dey P., Chakraborty S., Rachagani S., Senapati S., Singh P., Gurumurthy C.B., Band V., Hollingsworth M., and Batra S.K (2011, November) . Human Ecdysoneless Promotes Aerobic Glycolysis in Pancreatic Cancer Cells. Oral presentation at American Pancreatic Association Meeting, Chicago


Seminars presented

1.     Chakraborty S. "Sir, I am afraid we are going to have to wash out your lungs” Rosen-Castleman-Liebow Syndrome, an uncommon cause of dyspnea with an equally unusual treatment. Senior Seminar, University of Nebraska, March 24, 2014
2.     Chakraborty S. “Research from a resident's perspective”, Resident Noon Conference, University of Nebraska department of Internal Medicine, August 2012.
 
Invited articles and Editorials

1     Non-human prostate cancer cell lines. Senapati S., Chakraborty S., Nath I., Panda S.K., Patra R.C. and Batra S.K. Oncology Gastroenterology and Hepatology Reports. 2012; 1(1) 1-3
2     Introducing a New Journal: Free Radicals and Antioxidants. Chakraborty S.and Ahmed M.K K. Free Radicals and Antioxidants (Vol 1, Issue 1, Jan-Mar, 2011, 01-03)
3     From Small Steps to Giant Leaps- The Second Issue. Chakraborty S. Free Radicals and Antioxidants (Vol.1, Issue 2, April-June 2011)
4     Diabetes mellitus and oxidative stress in the Gastrointestinal Tract- Connecting the dots. Chakraborty S. Free Radicals and Antioxidants (Vol 1., Issue 3, July-Sep 2011)
5     Editorial: IL23 as a novel serum based biomarker in Ulcerative colitis. Chakraborty S. Gastroenterology and Hepatology from Bed to Bench 2012;5(1):1-2
6     Editorial: Celebrating one year of Free Radicals and Antioxidants. Chakraborty S. Free Radicals and Antioxidants. Vol. 1 Issue 4, Oct-Dec, 2011
7     Introducing a new Journal- Oncology Gastroenterology and Hepatology Reports. Chakraborty S. OGH Reports. Volume 1, Issue 1, Page 1-4.
8     Pancreatic cancer screening for high risk individuals: A clinical perspective. Singh S, Bhat I., Chakraborty S., Sasson A. OGH Reports. Volume 1, Issue 1, Page 10-14
9     Editorial: Moving Forward: Introducing the Second Issue. Chakraborty S., OGH Reports. Volume 2, Issue 1, Page 1 (DOI: 10.5530/ogh.2013.1.1)
10     Editorial: Public Health Practices and Perception in the spotlight. Chakraborty S., International Journal of Medicine and Public Health. Volume 3. Issue 1 (in press).

Peer reviewing experience
Peer reviewer for ACG Case Reports, American Journal of Clinical Oncology, Annals of Gastroenterology, PLoS ONE, Cancer, Cancer Management and Research, Disease Markers, Journal of the Pancreas, Journal of Clinical Pathology, Molecular Vision, Oncology, Hormones and Cancer, DNA and Cell Biology, International Journal of Medical Sciences, Personalized Medicine, Current Medical Research and Opinion, Genetic Testing and Molecular Biomarkers, Human Pathology, American Journal of Physiology- Gastrointestinal and Liver Physiology, Molecular Diagnosis and Therapy, Cancer Biotherapy and Radiopharmaceuticals, Journal of Experimental and Clinical Cancer Research, The Irish Medical Journal, Acta Tropica, Journal of General Internal Medicine, Journal of Gastrointestinal Cancer, Breastfeeding Medicine, Pancreatology, The Breast, Gastroenterology and Hepatology from Bed to Bench, Cancer Letters, Clinical and Experimental Gastroenterology, Hepatitis Monthly, Scientometrics, Universal Journal of Medicine and Dentistry, Diabetology & Metabolic Syndrome, European Journal of Gastroenterology and Hepatology, Gastrointestinal Cancer: Targets and Therapy and the International Journal of Women's Health